Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Warrant Extension
View:
Post by consultant99 on Sep 29, 2022 5:57pm

Warrant Extension

Seriously adding another full year expiry for these warrants? 

Yes the company needs the money. BUT these warrant holders are getting another freebeee. The least the company could have done was change the terms of these warrants to require them to be exercised once the share price exceeds the strike price for a minimum number of days.
Comment by O12009 on Sep 29, 2022 7:25pm
Agree 
Comment by Mikee3003 on Sep 29, 2022 7:55pm
Hmm......would be interesting to know how many of these extended warrents are held by insiders???
Comment by 2b7f6fab on Sep 29, 2022 9:22pm
Wow, does a little happy dance
Comment by Infinity on Sep 30, 2022 4:49am
Consultant,  I agree the terms could have more restrictions, particularly in reference to purchase price and a no sale clause for a 3 month period.  Overall, I must admit,  the company is going in the right direction and Roger is poised to get back on the Saddle as CEO without his hands being tied by Ontario security commission.  I do feel a cautious momentum in sale price in ...more  
Comment by StevenBirch on Sep 30, 2022 8:07am
I have to say I didn't see any negatives from the warrant extension and combined with the small bridge PP everything seems to be falling into place. 
Comment by Oilminerdeluxe on Sep 30, 2022 9:04am
How about starting Q4 with a pr or two about ongoing and upcoming activities. I guess I will have to buy a few today. I can't let you get rich without me. (or poor)
Comment by Impalaman on Sep 30, 2022 9:14am
Oilminer---I have the suspicion that the 4TH Q---starting monday next week will bring a lot of buying---while the price is SSOOO cheap--the sale ends at 4.00 pm today.
Comment by Oilminerdeluxe on Sep 30, 2022 9:20am
That would be nice, impalaman.
Comment by Sunvalley on Sep 30, 2022 10:59am
I think that I might open up my squeaky purse a bit and buy a few more shares also before the "sale" closes. Love the fact that certain insiders are still buying with both hands while the general public is still unaware of what is happening in this niche of the medical world. Given the results to date and the explosive potential , I still cannot believe that TLT can still be had for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250